LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 126 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 4.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $41,000 | -84.7% | 20,677 | -57.1% | 0.06% | +281.2% |
| Q1 2019 | $268,000 | -10.7% | 48,152 | +70.8% | 0.02% | +14.3% |
| Q3 2018 | $300,000 | -41.5% | 28,200 | -34.1% | 0.01% | -33.3% |
| Q2 2018 | $513,000 | +10.3% | 42,800 | -21.1% | 0.02% | +10.5% |
| Q1 2018 | $465,000 | +48.6% | 54,266 | +71.0% | 0.02% | +35.7% |
| Q4 2017 | $313,000 | -44.6% | 31,733 | -7.8% | 0.01% | -53.3% |
| Q2 2017 | $565,000 | +59.6% | 34,400 | +39.3% | 0.03% | +87.5% |
| Q1 2017 | $354,000 | -25.5% | 24,700 | -28.2% | 0.02% | -42.9% |
| Q4 2016 | $475,000 | +173.0% | 34,400 | +136.0% | 0.03% | +250.0% |
| Q1 2016 | $174,000 | – | 14,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |